Skip to main content

Improving Design, Evaluation and Analysis of early drug development Studies

Objective

Drug development is a long and costly process which suffers from the major shortcoming that frequently failure is often only
determined during the final stage. Recently, it has been recognised that more care needs to be taken during the early stages
of development to avoid going into lengthy and costly confirmatory studies with ineffective or harmful treatments. To achieve
this goal it is essential to implement efficient methods for the design and analysis of such early development studies. The
expertise in this area is, however, limited at the moment and adequate methodology is only partially available. Using a
cross-sectorial, transnational approach, the IDEAS network brings together leading public and private sector researchers in
the field with ample experience in training to educate, promote and support the future leaders in medical statistics in general
and in the design and analysis of early developmental studies in particular.

Within the network, cross-sectorial, transnational teams will support young researchers with individual methodological
projects and devise an individually tailored training programme for them. Clinical advisors supplement the input of the
supervisory team and ensure practical relevance and uptake of the methods devised. The training activities are comprised of
a well-rounded mix of specialist, methodological components and generic, transferable skills. A mandatory set of networkwide
training activities is supplemented by individual training components and cross-sectorial secondments, and particular
attention is given to interaction and collaboration between researchers and supervisors across public and private sector
partners. At the end of their training the researchers will be uniquely qualified with expertise in the field, benefit from
experience in both public and private sector and can rely on a wide network of experts in the field in the future.

Field of science

  • /humanities/arts/modern and contemporary art/film

Call for proposal

H2020-MSCA-ITN-2014
See other projects for this call

Funding Scheme

MSCA-ITN-ETN - European Training Networks

Coordinator

UNIVERSITY OF LANCASTER
Address
Bailrigg
LA1 4YW Lancaster
United Kingdom
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 819 863,64

Participants (7)

MEDIZINISCHE UNIVERSITAET WIEN
Austria
EU contribution
€ 511 868,16
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
POLITECNICO DI TORINO
Italy
EU contribution
€ 516 122,64
Address
Corso Duca Degli Abruzzi 24
10129 Torino
Activity type
Higher or Secondary Education Establishments
INSTITUT CURIE

Participation ended

France
EU contribution
€ 0
Address
Rue D'ulm 26
75231 Paris
Activity type
Research Organisations
Bayer Pharma AG
Germany
EU contribution
€ 249 216,48
Address
Muellerstrasse 178
13353 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERSITAET BREMEN
Germany
EU contribution
€ 498 432,96
Address
Bibliothekstrasse 1
28359 Bremen
Activity type
Higher or Secondary Education Establishments
JANSSEN PHARMACEUTICA NV
Belgium
EU contribution
€ 250 560
Address
Turnhoutseweg 30
2340 Beerse
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 262 875,60
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations

Partners (2)

Aptiv Solutions
Germany
Address
Robert Perthel Str. 77A
50739 Köln
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Clinical Trials Consulting & Training Limited
United Kingdom
Address
Portway 53
MK18 3PL North Marston
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)